These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6405214)

  • 1. [Malaria prevention with Fansidar].
    Wiedermann G; Stemberger H; Leimer R
    MMW Munch Med Wochenschr; 1983 Mar; 125(11):207-9. PubMed ID: 6405214
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerability of long-term prophylaxis with fansidar: a randomized double-blind study in Nigeria.
    Stemberger H; Leimer R; Wiedermann G
    Acta Trop; 1984 Dec; 41(4):391-9. PubMed ID: 6152120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance and haematological findings with antimalarials (chloroquine and Fansidar [pyrimethamine plus sulfadoxine]) in adults and children during field trials in Nigeria.
    Ekanem OJ; Bonmarchand M
    Acta Trop; 1980 Sep; 37(3):249-52. PubMed ID: 6106362
    [No Abstract]   [Full Text] [Related]  

  • 4. Concurrent chloroquine- and Fansidar-resistant Plasmodium falciparum: an imported case into Zimbabwe.
    Dallas AB; Okwanga PN; Mutambu SL; Pfumojena JW
    J Trop Med Hyg; 1986 Oct; 89(5):265-8. PubMed ID: 3540319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jan; 35(2):21-22, 27. PubMed ID: 3001495
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
    De Geus A; Meuwissen JH; van Rijn A
    Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of treatment with chloroquine, fansidar and dabequin of Plasmodium falciparum carriers, residing in a hyperendemic focus of malaria (the city of Bagamoyo, Northeastern Tanzania)].
    Kuznetsov RL; Kilama V; Peĭn D; Kampbell SS; Stori D
    Med Parazitol (Mosk); 1985; (4):15-9. PubMed ID: 3903459
    [No Abstract]   [Full Text] [Related]  

  • 8. Kenyan chloroquin, fansidar and quninine resistant P. Falciparum.
    Turner GD
    Cent Afr J Med; 1984 Jul; 30(7):136-7. PubMed ID: 6386173
    [No Abstract]   [Full Text] [Related]  

  • 9. Compared response to chloroquine, fansidar, quinine, and quinidine slow release of infections with Plasmodium falciparum in the Kivu region of Zaire.
    Delacollette C; Cibanguka J; Buregea H; Nkera J
    Acta Leiden; 1987; 55():159-62. PubMed ID: 3321832
    [No Abstract]   [Full Text] [Related]  

  • 10. [Malaria in 1985: new recommendations].
    Hemmer R
    Bull Soc Sci Med Grand Duche Luxemb; 1985; 122(1):19-20. PubMed ID: 4042266
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of malaria prophylaxis in peninsular Malaysia using chloroquine and a combination of sulphadoxine and pyrimethamine.
    Ponnampalam JT
    J Trop Med Hyg; 1978 Oct; 81(10):198-203. PubMed ID: 366165
    [No Abstract]   [Full Text] [Related]  

  • 12. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP; Wetsteyn JC; Meuwissen JH
    Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems encountered with using Fansidar as prophylaxis for malaria.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 May; 31(17):232-4. PubMed ID: 6804785
    [No Abstract]   [Full Text] [Related]  

  • 14. Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.
    Herzog C; Kibbler CC; Ellis CJ; Mtawali CV
    Br Med J (Clin Res Ed); 1983 Oct; 287(6397):947-8. PubMed ID: 6412900
    [No Abstract]   [Full Text] [Related]  

  • 15. Indications for the use of Fansidar in malaria.
    Schwartz IK; Campbell CC
    N Engl J Med; 1982 Jul; 307(3):194. PubMed ID: 7088068
    [No Abstract]   [Full Text] [Related]  

  • 16. Fansidar in malaria prophylaxis.
    Bradley DJ; Hall AP; Peters W; Warhurst D
    Br Med J (Clin Res Ed); 1985 Jul; 291(6488):136. PubMed ID: 3926082
    [No Abstract]   [Full Text] [Related]  

  • 17. Falciparum malaria resistant to chloroquine and Fansidar.
    Jaatinen M; Kihamia CM; McLarty DG
    Br Med J (Clin Res Ed); 1984 Jan; 288(6410):65. PubMed ID: 6418318
    [No Abstract]   [Full Text] [Related]  

  • 18. Falciparum malaria resistant to chloroquine and Fansidar: implications for prophylaxis.
    Eyre SJ
    Br Med J (Clin Res Ed); 1984 Feb; 288(6417):644. PubMed ID: 6421416
    [No Abstract]   [Full Text] [Related]  

  • 19. [Unsuccessful effect of sulfadoxine-pyrimethamine in the treatment of falciparum malaria in Tanzania].
    Vestergaard Olsen V
    Ugeskr Laeger; 1983 Mar; 145(10):751. PubMed ID: 6344376
    [No Abstract]   [Full Text] [Related]  

  • 20. Failures of combined chloroquine and Fansidar prophylaxis in American travelers to East Africa.
    Miller KD; Lobel HO; Pappaioanou M; Patchen LC; Churchill FC
    J Infect Dis; 1986 Oct; 154(4):689-91. PubMed ID: 3528321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.